The Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban-An Oral, Direct Factor Xa Inhibitor.
Phase of Trial: Phase I
Latest Information Update: 27 Aug 2013
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Stroke; Venous thromboembolism
- Focus Pharmacodynamics; Pharmacokinetics
- 27 Aug 2013 New trial record